Concepedia

Godspower Akpomiemie

GA

Statistics

Publications

16

Citations

1.6K

H-Index

15

Active since

2008

Affiliations

University of the Witwatersrand(Current)

University of Liverpool

Imperial College London

University of Cape Town

University Medical Center Utrecht

Godspower Akpomiemie is an author at University of the Witwatersrand specializing in antiretroviral therapy, antiviral therapy, and pharmacotherapy.

ORCID

Publications per year

2008–2024

16

Publications

16

Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV

François Venter, Michelle Moorhouse, Simiso Sokhela et al. · New England Journal of Medicine · 2019 · 717 citations · Full text

, , +17

Dolutegravir with emtricitabine and tenofovir alafenamide or tenofovir disoproxil fumarate versus efavirenz, emtricitabine, and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection (ADVANCE): week 96 results from a randomised, phase 3, non-inferiority trial

François Venter, Simiso Sokhela, Bryony Simmons et al. · The Lancet HIV · 2020 · 260 citations · Full text

, , +17

Impact of aciclovir on genital and plasma HIV-1 RNA in HSV-2/HIV-1 co-infected women: a randomized placebo-controlled trial in South Africa

Sinéad Delany, Nonkululeko Mlaba, Tim Clayton et al. · AIDS · 2009 · 96 citations · Full text

, , +17

Pregnancy, Contraceptive Use, and HIV Acquisition in HPTN 039: Relevance for HIV Prevention Trials Among African Women

Stewart E. Reid, James Y. Dai, Jing Wang et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 91 citations

, , +16

<i>CYP2B6</i> Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz

Rulan Griesel, Gary Maartens, Maxwell Chirehwa et al. · Clinical Infectious Diseases · 2020 · 85 citations · Full text

, , +15

1–5 of 16